Arrowhead Research (ARWR) Ends 1Q with $77M to Focus on HBV and AAT; Piper Jaffray Reiterates Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
After-Hours Stock Movers 02/09: (LLNW) (EDE) (MKTO) Higher; (MSTX) (SCTY) (P) Lower (more...)
February 9, 2016 6:12 PM ESTMast Therapeutics, Inc. (NYSE: MSTX) 37% LOWER; announced that it intends to offer shares of common stock and warrants to purchase common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
SolarCity (Nasdaq: SCTY) 32.4% LOWER; reported Q4 EPS of ($2.37), $0.22 better than the analyst estimate of ($2.59). Revenue was $115 million, versus... More
Arrowhead Research (ARWR) Tops Q2 EPS by 9c
February 9, 2016 4:47 PM ESTArrowhead Research (NASDAQ: ARWR) reported Q2 EPS of ($0.32), $0.09 better than the analyst estimate of ($0.41).
For earnings history and earnings-related data on Arrowhead Research (ARWR) click here.
... More